The research, evidence and thinking behind Preologi’s screening services – and the science we’re watching next.
A US study in over 6,600 adults over 50. When the Galleri® test flagged a signal, it pointed to the right place 97% of the time.
The NHS-Galleri trial followed over 140,000 people. Its main goal wasn't met — but the most advanced, stage IV diagnoses fell
PATHFINDER 2 followed nearly 36,000 adults over 50 across the US and Canada — the largest look yet at how well the test performs.
A follow-up asked how people coped emotionally with cancer blood testing. Most reported little distress, and those who got a signal returned to normal within a year.